Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7920631, 13 pages
http://dx.doi.org/10.1155/2016/7920631
Research Article

Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy

1Ophthalmology Department, Peking University People’s Hospital, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing Key Laboratory for the Diagnosis and Treatment of Retinal and Choroid Diseases, Beijing 100044, China
2Department of Ophthalmology, QiLu Hospital, Shandong University, Jinan, Shandong 250012, China

Received 16 February 2016; Accepted 17 May 2016

Academic Editor: Eeva Moilanen

Copyright © 2016 Xiao-Li Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Pastor, M. C. Méndez, M. A. de la Fuente et al., “Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening,” Ophthalmic Research, vol. 38, no. 4, pp. 193–200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Nagasaki, K. Shinagawa, and M. Mochizuki, “Risk factors for proliferative vitreoretinopathy,” Progress in Retinal and Eye Research, vol. 17, no. 1, pp. 77–98, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Y. L. Oberstein, J. Byun, D. Herrera, E. A. Chapin, S. K. Fisher, and G. P. Lewis, “Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration,” Molecular Vision, vol. 17, pp. 1794–1805, 2011. View at Google Scholar · View at Scopus
  4. G. Velez, A. R. Weingarden, B. A. Tucker, H. Lei, A. Kazlauskas, and M. J. Young, “Retinal pigment epithelium and müller progenitor cell interaction increase müller progenitor cell expression of PDGFRα and ability to induce proliferative vitreoretinopathy in a rabbit model,” Stem Cells International, vol. 2012, Article ID 106486, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Pastor, J. Rojas, S. Pastor-Idoate, S. Di Lauro, L. Gonzalez-Buendia, and S. Delgado-Tirado, “Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences,” Progress in Retinal and Eye Research, vol. 51, pp. 125–155, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Chiba, “The retinal pigment epithelium: an important player of retinal disorders and regeneration,” Experimental Eye Research, vol. 123, pp. 107–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Strauss, “The retinal pigment epithelium in visual function,” Physiological Reviews, vol. 85, no. 3, pp. 845–881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Lee, S. J. O'Meara, C. O'Brien, and R. Kane, “The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy,” Investigative Ophthalmology and Visual Science, vol. 48, no. 9, pp. 4291–4299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. N. Moysidis, A. Thanos, and D. G. Vavvas, “Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside,” Mediators of Inflammation, vol. 2012, Article ID 815937, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kalluri, “EMT: when epithelial cells decide to become mesenchymal-like cells,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1417–1419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Guan, K. Handa, and S.-I. Hakomori, “Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 18, pp. 7461–7466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Wynn and T. R. Ramalingam, “Mechanisms of fibrosis: therapeutic translation for fibrotic disease,” Nature Medicine, vol. 18, no. 7, pp. 1028–1040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Lee and C. M. Nelson, “New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis,” International Review of Cell and Molecular Biology, vol. 294, pp. 171–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Tamiya and H. J. Kaplan, “Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy,” Experimental Eye Research, vol. 142, pp. 26–31, 2016. View at Publisher · View at Google Scholar
  15. K. Umazume, R. Tsukahara, L. Liu et al., “Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy,” American Journal of Pathology, vol. 184, no. 5, pp. 1419–1428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Takahashi, A. Haga, and H. Tanihara, “Merlin regulates epithelial-to-mesenchymal transition of ARPE-19 cells via TAK1-p38MAPK-mediated activation,” Investigative Ophthalmology and Visual Science, vol. 56, no. 4, pp. 2449–2458, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Lv, Y. Gao, H. Guan et al., “Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines,” Oncology Letters, vol. 10, no. 4, pp. 2591–2597, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Sullivan and X. Lu, “ASPP: a new family of oncogenes and tumour suppressor genes,” British Journal of Cancer, vol. 96, no. 2, pp. 196–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Iwabuchi, P. L. Bartel, B. Li, R. Marraccino, and S. Fields, “Two cellular proteins that bind to wild-type but not mutant p53,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 6098–6102, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Vives, E. A. Slee, and X. Lu, “ASPP2: a gene that controls life and death in vivo,” Cell Cycle, vol. 5, no. 19, pp. 2187–2190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Sottocornola, C. Royer, V. Vives et al., “ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development,” Developmental Cell, vol. 19, no. 1, pp. 126–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, F. Bu, C. Royer et al., “ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1,” Nature Cell Biology, vol. 16, no. 11, pp. 1092–1104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Pastor-Idoate, I. Rodriguez-Hernández, J. Rojas et al., “The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the retina 4 project,” Ophthalmology, vol. 120, no. 3, pp. 623–628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Azzolini, I. S. Pagani, C. Pirrone et al., “Expression of VEGF-A, Otx homeobox and p53 family genes in proliferative vitreoretinopathy,” Mediators of Inflammation, vol. 2013, Article ID 857380, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Kampa, M. Bonin, and C. D. Lopez, “New insights into the expanding complexity of the tumor suppressor ASPP2,” Cell Cycle, vol. 8, no. 18, pp. 2871–2876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Wilson, B. Morquette, M. Abdouh et al., “ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo,” Journal of Neuroscience, vol. 33, no. 5, pp. 2205–2216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Huang, Y. Xu, W. Yu et al., “Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy,” Investigative Ophthalmology and Visual Science, vol. 51, no. 6, pp. 3193–3204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Yoshida, Y. Kubo, Y. Kobayashi et al., “Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema,” British Journal of Ophthalmology, vol. 99, no. 7, pp. 960–966, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. X.-Z. Zheng, L.-F. Du, and H.-P. Wang, “An immunohistochemical analysis of a rat model of proliferative vitreoretinopathy and a comparison of the expression of TGF-β and PDGF among the induction methods,” Bosnian Journal of Basic Medical Sciences, vol. 10, no. 3, pp. 204–209, 2010. View at Google Scholar · View at Scopus
  30. F. F. Behar-Cohen, B. Thillaye-Goldenberg, T. de Bizemont, M. Savoldelli, D. Chauvaud, and Y. de Kozak, “EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR,” Investigative Ophthalmology and Visual Science, vol. 41, no. 12, pp. 3915–3924, 2000. View at Google Scholar · View at Scopus
  31. F. Lebrun-Julien, L. Duplan, V. Pernet et al., “Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism,” Journal of Neuroscience, vol. 29, no. 17, pp. 5536–5545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Dvashi, M. Goldberg, O. Adir, M. Shapira, and A. Pollack, “TGF-β1 induced transdifferentiation of RPE cells is mediated by TAK1,” PLoS ONE, vol. 10, no. 4, Article ID e122229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. C.-L. Chen, C.-M. Liang, Y.-H. Chen, M.-C. Tai, D.-W. Lu, and J.-T. Chen, “Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation,” Acta Ophthalmologica, vol. 90, no. 5, pp. e389–e398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Chen, W. Xiao, W. Wang, L. Luo, S. Ye, and Y. Liu, “The complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells,” PLoS ONE, vol. 9, no. 5, article e96365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. W.-K. Liu, X.-Y. Jiang, J.-K. Ren, and Z.-X. Zhang, “Expression pattern of the ASPP family members in endometrial endometrioid adenocarcinoma,” Onkologie, vol. 33, no. 10, pp. 500–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Tamiya, L. Liu, and H. J. Kaplan, “Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact,” Investigative Ophthalmology and Visual Science, vol. 51, no. 5, pp. 2755–2763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. N.-G. Kim, E. Koh, X. Chen, and B. M. Gumbiner, “E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 11930–11935, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Stockinger, A. Eger, J. Wolf, H. Beug, and R. Foisner, “E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity,” The Journal of Cell Biology, vol. 154, no. 6, pp. 1185–1196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. C. Ruan, Y. Wang, N. Da Silva et al., “CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway,” Journal of Cell Science, vol. 127, no. 20, pp. 4396–4408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-C. Chen, Y.-T. Zhu, S.-Y. Chen, and S. C. Tseng, “Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition,” Laboratory Investigation, vol. 92, no. 5, pp. 676–687, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. G. B. Park, D. Kim, Y. S. Kim et al., “Regulation of ADAM10 and ADAM17 by sorafenib inhibits epithelial-to-mesenchymal transition in epstein-barr virus-infected retinal pigment epithelial cells,” Investigative Ophthalmology and Visual Science, vol. 56, no. 9, pp. 5162–5173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. R. O. Schlingemann, “Role of growth factors and the wound healing response in age-related macular degeneration,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 1, pp. 91–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. S. He, M. L. Jin, V. Worpel, and D. R. Hinton, “A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization,” Archives of Ophthalmology, vol. 121, no. 9, pp. 1283–1288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Oh, H. Takagi, C. Takagi et al., “The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes,” Investigative Ophthalmology & Visual Science, vol. 40, no. 9, pp. 1891–1898, 1999. View at Google Scholar · View at Scopus
  45. H. Yamamoto, H. Hayashi, H. Uchida, H. Kato, and K. Oshima, “Increased soluble interleukin-6 receptor in vitreous fluid of proliferative vitreoretinopathy,” Current Eye Research, vol. 26, no. 1, pp. 9–14, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Baudouin, D. Fredj-Reygrobellet, F. Brignole, F. Negre, P. Lapalus, and P. Gastaud, “Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy,” Ophthalmic Research, vol. 25, no. 1, pp. 52–59, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Morescalchi, S. Duse, E. Gambicorti, M. R. Romano, C. Costagliola, and F. Semeraro, “Proliferative Vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid,” Mediators of Inflammation, vol. 2013, Article ID 269787, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Rojas, I. Fernandez, J. C. Pastor et al., “A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project,” Ophthalmology, vol. 117, no. 12, pp. 2417–2423.e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. R. B. Wilkins and D. R. Kulwin, “Wound healing,” Ophthalmology, vol. 86, no. 4, pp. 507–510, 1979. View at Publisher · View at Google Scholar · View at Scopus
  50. K. C. Dunn, A. E. Aotaki-Keen, F. R. Putkey, and L. M. Hjelmeland, “ARPE-19, a human retinal pigment epithelial cell line with differentiated properties,” Experimental Eye Research, vol. 62, no. 2, pp. 155–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. S. A. Morales, D. G. Telander, S. Mareninov et al., “Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells,” Experimental Eye Research, vol. 102, pp. 10–16, 2012. View at Publisher · View at Google Scholar · View at Scopus